AKTIVIITAS ANTIOKSIDAN ANTIHIPERLIPIDEMIA DAN ANTIHIPERTENSI DARI EKSTRAK ETANOL DAUN KEDABU (Sonneratia ovata. Backer)
DOI:
https://doi.org/10.36387/jiis.v10i1.2245Keywords:
Sonneratia ovata Backer, Flavonoid, ABTS, ACE inhibitor, LipaseAbstract
Kedabu (Sonneratia ovata. Backer) is one type of mangrove from the genus Sonneratia with high flavonoid content that has the potential as an antioxidant. The flavonoid content in the kedabu plant includes sonnerphenolic, vanillin, (-)-(R)-nyasol, (-)-(R)-4’-O-methylnyasol, maslinic acid, lingueresinol and gallic acid. Flavonoids as antioxidants can improve blood lipid profiles by lowering total cholesterol, triglycerides, and LDL, and increasing HDL. In addition, flavonoids can inhibit the activity of Angiotensin-converting enzyme (ACE) so that it has the potential as an antihypertensive. This study aims to examine the potential of kedabu leaf extract as an antioxidant, antihypertensive and antihyperlipidemic agent tested in vitro. Antioxidant testing was carried out using the ABTS (2,2-azinobis-3-ethylbenzothiazoline-6sulfonate) method, antihypertension testing was carried out by inhibiting Angiotensin converting enzyme and antihyperlipidemia testing was carried out by inhibiting the lipase enzyme. The results of the study showed that the total flavonoid content was 38.248 ± 0.142 mgQE / g with an antioxidant capacity with an IC50 value of 28.30 ± 0.558 ppm. From the Angiotensin converting enzyme inhibition and lipase enzyme inhibition tests, the IC50 values were 44.851 ± 0.130 ppm and 39.133 ± 0.889 ppm, respectively. Based on these results, the kedabu leaf extract showed antihypertensive and antihyperlipidemia activities by inhibiting the activity of Angiotensin converting enzyme and lipase enzymes.
References
Adwas, A. A., Elsayed, A., Azab, A. E., & Quwaydir, F. A. (2019). Oxidative stress and antioxidant mechanisms in human body. J. Appl. Biotechnol. Bioeng, 6(1), 43–47. DOI: https://doi.org/10.15406/jabb.2019.06.00173
Cano, A., Maestre, A. B., Hernández-Ruiz, J., & Arnao, M. B. (2023). ABTS/TAC methodology: Main milestones and recent applications. Processes, 11(1), 185. DOI: https://doi.org/10.3390/pr11010185
Cao, Y., Xie, L., Liu, K., Liang, Y., Dai, X., Wang, X., Lu, J., Zhang, X., & Li, X. (2021). The antihypertensive potential of flavonoids from Chinese Herbal Medicine: A review. Pharmacological Research, 174, 105919. DOI: https://doi.org/10.1016/j.phrs.2021.105919
Carey, R. M., Moran, A. E., & Whelton, P. K. (2022). Treatment of hypertension: a review. Jama, 328(18), 1849–1861. DOI: https://doi.org/10.1001/jama.2022.19590
Ciumărnean, L., Milaciu, M. V., Runcan, O., Vesa, Ștefan C., Răchișan, A. L., Negrean, V., Perné, M.-G., Donca, V. I., Alexescu, T.-G., & Para, I. (2020). The effects of flavonoids in cardiovascular diseases. Molecules, 25(18), 4320. DOI: https://doi.org/10.3390/molecules25184320
Furi, M., Al Basit, N., Ikhtiarudin, I., & Utami, R. (2020). Penentuan Total Fenolik, Flavonoid dan Uji Aktivitas Antioksidan Ekstrak dan Fraksi Daun Kedabu (Sonneratia ovata Backer). JFIOnline| Print ISSN 1412-1107| e-ISSN 2355-696X, 12(1), 48–59. DOI: https://doi.org/10.35617/jfionline.v12i1.56
Gouveia, H. J. C. B., Urquiza-Martínez, M. V, Manhães-de-Castro, R., Costa-de-Santana, B. J. R., Villarreal, J. P., Mercado-Camargo, R., Torner, L., de Souza Aquino, J., Toscano, A. E., & Guzmán-Quevedo, O. (2022). Effects of the treatment with flavonoids on metabolic syndrome components in humans: A systematic review focusing on mechanisms of action. International Journal of Molecular Sciences, 23(15), 8344. DOI: https://doi.org/10.3390/ijms23158344
Haider, R. (2023). Cardiovascular Risk Factors. Toxicology and Applied Pharmacology Insights, 6(1), 77–87. DOI: https://doi.org/10.33140/TAPI.06.01.10
Hamdan, I. I., Kasabri, V. N., Al-Hiari, Y. M., El-Sabawi, D., & Zalloum, H. (2019). Pancreatic lipase inhibitory activity of selected pharmaceutical agents. Acta Pharmaceutica, 69(1), 1–16. DOI: https://doi.org/10.2478/acph-2019-0010
Hedayatnia, M., Asadi, Z., Zare-Feyzabadi, R., Yaghooti-Khorasani, M., Ghazizadeh, H., Ghaffarian-Zirak, R., Nosrati-Tirkani, A., Mohammadi-Bajgiran, M., Rohban, M., & Sadabadi, F. (2020). Dyslipidemia and cardiovascular disease risk among the MASHAD study population. Lipids in Health and Disease, 19, 1–11. DOI: https://doi.org/10.1186/s12944-020-01204-y
Hermanto, S., Septiana, A., Putera, D. K., Hatiningsih, F., & Muawanah, A. (2019). ACE inhibitory and antioxidative bioactive peptides derived from hydrolyzed soy milk. Molekul, 14(1), 56–63. DOI: https://doi.org/10.20884/1.jm.2019.14.1.506
Islam, S. U., Ahmed, M. B., Ahsan, H., & Lee, Y.-S. (2021). Recent molecular mechanisms and beneficial effects of phytochemicals and plant-based whole foods in reducing LDL-C and preventing cardiovascular disease. Antioxidants, 10(5), 784. DOI: https://doi.org/10.3390/antiox10050784
Khan, J., Deb, P. K., Priya, S., Medina, K. D., Devi, R., Walode, S. G., & Rudrapal, M. (2021). Dietary flavonoids: Cardioprotective potential with antioxidant effects and their pharmacokinetic, toxicological and therapeutic concerns. Molecules, 26(13), 4021. DOI: https://doi.org/10.3390/molecules26134021
Liu, B., Wang, X., Wang, Y., Chen, X., Jin, X., & Luo, X. (2023). Review of compounds and activities from mangrove Sonneratia genus and their endophytes. Journal of Holistic Integrative Pharmacy, 4(3), 218–227. https://doi.org/https://doi.org/10.1016/j.jhip.2023.11.003 DOI: https://doi.org/10.1016/j.jhip.2023.11.003
Liu, Y., Luo, J., Peng, L., Zhang, Q., Rong, X., Luo, Y., & Li, J. (2024). Flavonoids: Potential therapeutic agents for cardiovascular disease. Heliyon, 10(12). DOI: https://doi.org/10.1016/j.heliyon.2024.e32563
Lukas, L. M. (2023). The potential of plant extracts containing flavonoids as anti-hyperlipidemia: A literature review. Indonesia Journal of Biomedical Science, 17(2), 224–226. DOI: https://doi.org/10.15562/ijbs.v17i2.481
Maaliki, D., Shaito, A. A., Pintus, G., El-Yazbi, A., & Eid, A. H. (2019). Flavonoids in hypertension: A brief review of the underlying mechanisms. Current Opinion in Pharmacology, 45, 57–65. DOI: https://doi.org/10.1016/j.coph.2019.04.014
Mahdavi, A., Bagherniya, M., Fakheran, O., Reiner, Ž., Xu, S., & Sahebkar, A. (2020). Medicinal plants and bioactive natural compounds as inhibitors of HMG‐CoA reductase: A literature review. BioFactors, 46(6), 906–926. DOI: https://doi.org/10.1002/biof.1684
Mammen, D. (2022). Chemical perspective and drawbacks in flavonoid estimation assays. Front. Nat. Prod. Chem, 10, 189–228. DOI: https://doi.org/10.2174/9789815040760122100007
Maryam, S., Suhaenah, A., & Amrullah, N. F. (2020). Uji Aktivitas Penghambatan Enzim Α-Glukosidase Ekstrak Etanol Biji Buah Alpukat Sangrai (Persea americana Mill.) Secara In Vitro. As-Syifaa Jurnal Ilmiah, 12(1), 51–56. DOI: https://doi.org/10.33096/jifa.v12i1.619
Muchtaridi, M., Fauzi, M., Khairul Ikram, N. K., Mohd Gazzali, A., & Wahab, H. A. (2020). Natural Flavonoids as Potential Angiotensin-Converting Enzyme 2 Inhibitors for Anti-SARS-CoV-2. In Molecules (Vol. 25, Issue 17). https://doi.org/10.3390/molecules25173980 DOI: https://doi.org/10.3390/molecules25173980
Nguyen, L. T. T., Nguyen, T. T., Nguyen, H. N., & Bui, Q. T. P. (2024). Analysis of active compounds and bioactivity of leaves extracts of Sonneratia species. Engineering Reports, e12870. DOI: https://doi.org/10.1002/eng2.12870
Nurmalasari, F., Ersam, T., & Fatmawati, S. (2016). Isolasi senyawa antioksidan dari kulit batang sonneratia ovata backer. Jurnal Sains Dan Seni ITS, 5(2).
Okta, F. N., Aulena, D. N., Yuliana, P. I., & Tambunan, R. M. (2023). In Vitro Angiotensin-Converting Enzyme (ACE) Inhibition Test on Extract Dayak Onion Herb (Eleutherine americana (Aubl.) Merr. ex K. Heyne). In 71 & M. Moektiwardoyo (Eds.), Sciences of Pharmacy (Vol. 2, Issue 2, p. 63). ETFLIN. https://doi.org/https://doi.org/10.58920/sciphar02020024 DOI: https://doi.org/10.58920/sciphar02020024
Paredes, M. D., Romecín, P., Atucha, N. M., O’Valle, F., Castillo, J., Ortiz, M. C., & García-Estañ, J. (2018). Moderate effect of flavonoids on vascular and renal function in spontaneously hypertensive rats. Nutrients, 10(8), 1107. DOI: https://doi.org/10.3390/nu10081107
Pliego, J., Mateos-Díaz, J., Rodríguez González, J., Valero, F., Baeza, M., Femat, R., Camacho, R., Sandoval, G., & Herrera-López, E. J. (2015). Monitoring Lipase/Esterase Activity by Stopped Flow in a Sequential Injection Analysis System Using p-Nitrophenyl Butyrate. Sensors, 15, 2798–2811. https://doi.org/10.3390/s150202798 DOI: https://doi.org/10.3390/s150202798
Rajan, L., Palaniswamy, D., & Mohankumar, S. K. (2020). Targeting obesity with plant-derived pancreatic lipase inhibitors: A comprehensive review. Pharmacological Research, 155, 104681. DOI: https://doi.org/10.1016/j.phrs.2020.104681
Rana, A. C., & Gulliya, B. (2019). Chemistry and pharmacology of flavonoids-A review. Indian Journal of Pharmaceutical Education & Research, 53(1). DOI: https://doi.org/10.5530/ijper.53.1.3
Sánchez, M., Romero, M., Gómez-Guzmán, M., Tamargo, J., Pérez-Vizcaino, F., & Duarte, J. (2019). Cardiovascular effects of flavonoids. Current Medicinal Chemistry, 26(39), 6991–7034. DOI: https://doi.org/10.2174/0929867326666181220094721
Shraim, A. M., Ahmed, T. A., Rahman, M. M., & Hijji, Y. M. (2021). Determination of total flavonoid content by aluminum chloride assay: A critical evaluation. Lwt, 150, 111932. DOI: https://doi.org/10.1016/j.lwt.2021.111932
Downloads
Published
Issue
Section
License
Copyright (c) 2025 JIIS (Jurnal Ilmiah Ibnu Sina): Ilmu Farmasi dan Kesehatan
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
